Aims: Nitric oxide (NO) is associated with neuroinflammation in the central nervous system. We determined whether NO increases the expression of aquaporin-4 (AQP4) in optic nerve astrocytes of rats. Methods: Isolated astrocytes were incubated under normoxic or hypoxic conditions with or without glucose (5.5 mM). The astrocytes were also exposed to different concentrations of S-nitroso-N-acetyl-DL-penicillamine (SNAP, 1.0-100 μM), an NO donor. The expression of AQP4 was determined by Western blot analyses, and NO formation was measured by the Griess reaction. The changes in astrocytic cellular volumes were determined by flow cytometry. Results: Hypoxia and glucose deprivation increased AQP4 expression and NO formation. Inhibition of NO synthetase (NOS) significantly suppressed these changes. SNAP caused a significant increase in AQP4 expression, and the increase was significantly suppressed by carboxy-PTIO, a scavenger of NO. Incubation with 8-Br-cyclic guanosine monophosphate (cGMP) mimicked the effects of SNAP, while the addition of either 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ; inhibitor of soluble guanylate cyclase) or KT5823 (protein kinase G inhibitor) suppressed the SNAP-induced increase in AQP4 significantly. SNAP also caused a significant increase in astrocytic cellular volume through the AQP4 channels. Conclusions: NO increased the AQP4 expression of optic nerve astrocytes through the cGMP/protein kinase G pathway and enlarged their volume.

Keywords:
Optic nerve astrocyte, Western blot, Protein kinase G, Nitric oxide, Aquaporin-4
1.
Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP: Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 1997;17:171-180.
2.
Amiry-Moghaddam M, Ottersen OP: The molecular basis of water transport in the brain. Nat Rev Neurosci 2003;4:991-1001.
3.
Zhou J, Kong H, Hua X, Xiao M, Ding J, Hu G: Altered blood-brain barrier integrity in adult aquaporin-4 knockout mice. Neuroreport 2008;19:1-5.
4.
Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, Chan P, Verkman AS: Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000;6:159-163.
5.
Papadopoulos MC, Manley GT, Krishna S, Verkman AS: Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 2004;18:1291-1293.
6.
Ribeiro Mde C, Hirt L, Bogousslavsky J, Regli L, Badaut J: Time course of aquaporin expression after transient focal cerebral ischemia in mice. J Neurosci Res 2006;83:1231-1240.
7.
Zador Z, Bloch O, Yao X, Manley GT: Aquaporins: role in cerebral edema and brain water balance. Prog Brain Res 2007;161:185-194.
8.
Tourdias T, Mori N, Dragonu I, Cassagno N, Boiziau C, Aussudre J, Brochet B, Moonen C, Petry KG, Dousset V: Differential aquaporin 4 expression during edema build-up and resolution phases of brain inflammation. J Neuroinflammation 2011;8:143.
9.
Suzuki H, Oku H, Horie T, Morishita S, Tonari M, Oku K, Okubo A, Kida T, Mimura M, Fukumoto M, Kojima S, Takai S, Ikeda T: Changes in expression of aquaporin-4 and aquaporin-9 in optic nerve after crushing in rats. PLoS One 2014;9:e114694.
10.
Shareef S, Sawada A, Neufeld AH: Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Invest Ophthalmol Vis Sci 1999;40:2884-2891.
11.
Koch KW, Lambrecht HG, Haberecht M, Redburn D, Schmidt HH: Functional coupling of a Ca2+/calmodulin-dependent nitric oxide synthase and a soluble guanylyl cyclase in vertebrate photoreceptor cells. EMBO J 1994;13:3312-3320.
12.
Brown GC: Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 1995;369:136-139.
13.
Figueroa S, Oset-Gasque MJ, Arce C, Martinez-Honduvilla CJ, Gonzalez MP: Mitochondrial involvement in nitric oxide-induced cellular death in cortical neurons in culture. J Neurosci Res 2006;83:441-449.
14.
Sato T, Oku H, Tsuruma K, Katsumura K, Shimazawa M, Hara H, Sugiyama T, Ikeda T: Effect of hypoxia on susceptibility of RGC-5 cells to nitric oxide. Invest Ophthalmol Vis Sci 2010;51:2575-2586.
15.
Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA: S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006;441:513-517.
16.
Schinder AF, Olson EC, Spitzer NC, Montal M: Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci 1996;16:6125-6133.
17.
Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH: Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993;13:2651-2661.
18.
Wang Y, Tajkhorshid E: Nitric oxide conduction by the brain aquaporin AQP4. Proteins 2010;78:661-670.
19.
Gunnarson E, Zelenina M, Axehult G, Song Y, Bondar A, Krieger P, Brismar H, Zelenin S, Aperia A: Identification of a molecular target for glutamate regulation of astrocyte water permeability. Glia 2008;56:587-596.
20.
Samdani AF, Dawson TM, Dawson VL: Nitric oxide synthase in models of focal ischemia. Stroke 1997;28:1283-1288.
21.
Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL, Hong JS: Role of nitric oxide in inflammation-mediated neurodegeneration. Ann NY Acad Sci 2002;962:318-331.
22.
Cherian L, Hlatky R, Robertson CS: Nitric oxide in traumatic brain injury. Brain Pathol 2004;14:195-201.
23.
Kahle KT, Simard JM, Staley KJ, Nahed BV, Jones PS, Sun D: Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport. Physiology (Bethesda) 2009;24:257-265.
24.
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG: Improving bioscience research reporting: the arrive guidelines for reporting animal research. PLoS Biol 2010;8:e1000412.
25.
Morishita S, Oku H, Horie T, Tonari M, Kida T, Okubo A, Sugiyama T, Takai S, Hara H, Ikeda T: Systemic simvastatin rescues retinal ganglion cells from optic nerve injury possibly through suppression of astroglial NF-κB activation. PLoS One 2014;9:e84387.
26.
Feelisch M, Kotsonis P, Siebe J, Clement B, Schmidt HH: The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome p-450 enzymes involved in nitric oxide donor bioactivation. Mol Pharmacol 1999;56:243-253.
27.
Hidaka H, Kobayashi R: Pharmacology of protein kinase inhibitors. Annu Rev Pharmacol Toxicol 1992;32:377-397.
28.
Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, Nagano T: Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 1998;70:2446-2453.
29.
Hoffman RA, Johnson TS, Britt WB: Flow cytometric electronic direct current volume and radiofrequency impedance measurements of single cells and particles. Cytometry 1981;1:377-384.
30.
Bredt DS, Snyder SH: Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989;86:9030-9033.
31.
Fiscus RR: Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells. Neurosignals 2002;11:175-190.
32.
Lu M, Lee MD, Smith BL, Jung JS, Agre P, Verdijk MA, Merkx G, Rijss JP, Deen PM: The human AQP4 gene: definition of the locus encoding two water channel polypeptides in brain. Proc Natl Acad Sci USA 1996;93:10908-10912.
33.
Smith AJ, Jin BJ, Ratelade J, Verkman AS: Aggregation state determines the localization and function of M1- and M23-aquaporin-4 in astrocytes. J Cell Biol 2014;204:559-573.
34.
Moe SE, Sorbo JG, Sogaard R, Zeuthen T, Petter Ottersen O, Holen T: New isoforms of rat aquaporin-4. Genomics 2008;91:367-377.
35.
Klatzo I: Presidental address: neuropathological aspects of brain edema. J Neuropathol Exp Neurol 1967;26:1-14.
36.
Yu L, Yi J, Ye G, Zheng Y, Song Z, Yang Y, Song Y, Wang Z, Bao Q: Effects of curcumin on levels of nitric oxide synthase and AQP-4 in a rat model of hypoxia-ischemic brain damage. Brain Res 2012;1475:88-95.
37.
Kaur C, Sivakumar V, Yong Z, Lu J, Foulds WS, Ling EA: Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration. J Pathol 2007;212:429-439.
38.
Wang CC, Chio CC, Chang CH, Kuo JR, Chang CP: Beneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemia. BMC Pharmacol 2010;10:11.
39.
Terpolilli NA, Kim SW, Thal SC, Kuebler WM, Plesnila N: Inhaled nitric oxide reduces secondary brain damage after traumatic brain injury in mice. J Cereb Blood Flow Metab 2013;33:311-318.
40.
Konopacka A, Konopacki FA, Albrecht J: Protein kinase G is involved in ammonia-induced swelling of astrocytes. J Neurochem 2009;109:246-251.
41.
Nesic O, Lee J, Ye Z, Unabia GC, Rafati D, Hulsebosch CE, Perez-Polo JR: Acute and chronic changes in aquaporin 4 expression after spinal cord injury. Neuroscience 2006;143:779-792.
42.
Brahmachari S, Fung YK, Pahan K: Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J Neurosci 2006;26:4930-4939.
43.
Boran MS, Garcia A: The cyclic GMP-protein kinase G pathway regulates cytoskeleton dynamics and motility in astrocytes. J Neurochem 2007;102:216-230.
44.
Herrera M, Hong NJ, Garvin JL: Aquaporin-1 transports no across cell membranes. Hypertension 2006;48:157-164.
45.
McKee M, Scavone C, Nathanson JA: Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc Natl Acad Sci USA 1994;91:12056-12060.
46.
Sato T, Kamata Y, Irifune M, Nishikawa T: Inhibitory effect of several nitric oxide-generating compounds on purified Na+,K+-ATPase activity from porcine cerebral cortex. J Neurochem 1997;68:1312-1318.
47.
Illarionova NB, Gunnarson E, Li Y, Brismar H, Bondar A, Zelenin S, Aperia A: Functional and molecular interactions between aquaporins and Na,K-ATPase. Neuroscience 2009;168:915-925.
48.
Da T, Verkman AS: Aquaporin-4 gene disruption in mice protects against impaired retinal function and cell death after ischemia. Invest Ophthalmol Vis Sci 2004;45:4477-4483.
49.
Cui B, Sun JH, Xiang FF, Liu L, Li WJ: Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response. Exp Eye Res 2012;98:37-43.
50.
Li XM, Wendu RL, Yao J, Ren Y, Zhao YX, Cao GF, Qin J, Yan B: Abnormal glutamate metabolism in the retina of aquaporin 4 (AQP4) knockout mice upon light damage. Neurol Sci 2014;35:847-853.
51.
Zeng XN, Sun XL, Gao L, Fan Y, Ding JH, Hu G: Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes. Mol Cell Neurosci 2007;34:34-39.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.